Add-on Therapy: A patient whose blood pressure is not adequately controlled with amlodipine (or another dihydropyridine calcium-channel blocker) alone or with valsartan (or another angiotensin II receptor blocker) alone may be switched to combination therapy with (Amlodipine and Valsartan)
Whilst routine potassium monitoring is not required for all patients prescribed Wegovy, certain individuals are at increased risk of electrolyte disturbances and warrant closer biochemical surveillance
If you have insurance coverage or access through programs like LillyDirect, Zepbound eliminates the uncertainty and quality concerns associated with compounding
the difference lies in manufacturing location, regulatory pathway, and pricing structure
PubMed Dorr RT, Dvorakova K, Brooks C, Lines R, Levine N, et al